Equity Research Americas
U.S. Medical Supplies & Devices CS Virtual Diabetes Sessions: Key Take-Aways and Insights 16 June 2020
Research Analysts Matt Miksic 212-325-4381
matt.miksic@credit-suisse.com
Vik Chopra 212-325-1749
vik.chopra@credit-suisse.com
European Pharma Team 44 207 888 0304
creditsuisse.pharmateam@credit-suisse.com
DISCLOSURE APPENDIX AT THE BACK OF THIS REPORT CONTAINS IMPORTANT DISCLOSURES, ANALYST CERTIFICATIONS, LEGAL ENTITY DISCLOSURE AND THE STATUS OF NON-US ANALYSTS.
US Disclosure: Credit
Suisse does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.
6/16/2020
6/16/2020
Credit Suisse 2020 Virtual Sessions Executive Summary
We hosted a series of virtual ...
|
== 试读已结束，如需继续阅读敬请充值会员 ==
|
|
本站文章均为原创投稿，仅供下载参考，付费用户可查看完整且有格式内容！
(费用标准：38元/月，98元/年，微信支付秒开通！) |
| 升级为会员即可查阅全文 。如需要查阅全文，请 免费注册 或 登录会员 |
|
